Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of TNF-alpha Inhibitors in Spondyloarthritis
NCT00726804Phase 4Terminated
- Sponsor
- Rigshospitalet Glostrup
- Start
- Mar 2008
- Primary completion
- May 2012
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab, etanercept, infliximab in spondyloarthritis (SpA), sponsored by Rigshospitalet Glostrup. Started Mar 2008; status: terminated.
02
Drugs
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT00726804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726804.